Mathew Thomas, MD
Plastic and Reconstructive Surgery · Bel Air, MDNPI 1225234891
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,600 of the $4,575 with a category attached, or 78.7%. Microaire Surgical Instruments LLC accounts for 94.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $4,337 and has fallen 99.7% since, to $14 in 2025.
Across 17 payments — averaging $269.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microaire Surgical Instruments LLC$4K
- AbbVie$75
- Mentor Worldwide LLC$63
- Organogenesis Inc.$37
- Axogen$22
- Linvatec Corporation$21
- plus $58 from 4 others
What the payments were for
- Speaking & faculty fees$3,60079%
- Travel & lodging$70015%
- Food & beverage$2756%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microaire Surgical Instruments LLC | 4 | $4,300 |
| AbbVie | 3 | $75 |
| Mentor Worldwide LLC | 3 | $63 |
| Organogenesis Inc. | 1 | $37 |
| Axogen | 1 | $22 |
| Linvatec Corporation | 1 | $21 |
| Stryker | 1 | $16 |
| International Rehabilitative Sciences, Inc | 1 | $14 |
| Vapotherm Inc | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SMART RELEASE$4,300
How this compares
$4,575 in reported general payments places this provider in the 75th percentile of 55 plastic and reconstructive surgery providers in Maryland.
See all plastic and reconstructive surgery providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 12 | $63 |
| Oxycodone Hcl | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Bel Air
- Jeffrey HorowitzBel Air$504
- Bradley RobertsonBel Air$201
- Kristen BroderickBaltimore$40K
- Deasia JacobFrederick$24K
- Branko BojovicBaltimore$19K
- Gabriel del CorralWestminster$16K
- Jennifer SabinoBethesda$11K
- Christopher FleuryChevy Chase$10K
- Eric ChangColumbia$8K
- Scott AndochickFrederick$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.